Showing results (501-510 of 5,582) with videos related to
Sort By:
Pageof 559
Nuclear Medicine Communications|December 29, 2000
Is a low-dose Tc-99m-MIBI protocol suitable for first-pass RNV?A Tausig, P Knesewitsch, K Brinkbäumer, et al.Nuclear Medicine Communications|December 29, 2000
Comparison of methods for quantification of transient ischaemic dilation in myocardial perfusion SPETR A Peace, F I McKiddie, R T Staff, et al.Nuclear Medicine Communications|June 14, 2001
Protein binding of 99Tcm-DTPA compared with other GFR tracersM Rehling, L E Nielsen, J MarqversenNuclear Medicine Communications|June 14, 2001
Does inadequate exercise lower the accuracy of myocardial perfusion scintigraphy?N J Peng, G Y Mar, C P Liu, et al.Nuclear Medicine Communications|June 14, 2001
Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell linesM Rodrigues, W Kalinowska, C Zielinski, et al.Nuclear Medicine Communications|June 14, 2001
Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumoursJ J Mateos, X Setoain, J Ferre, et al.Nuclear Medicine Communications|June 14, 2001
Assessment of regional myocardial wall motion and thickening by gated 99Tcm-tetrofosmin SPECT: a comparison with magnetic resonance imagingF F Wahba, H J Lamb, J J Bax, et al.Nuclear Medicine Communications|June 14, 2001
Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumoursZ Ozcan, Z Burak, R Erinç, et al.Nuclear Medicine Communications|June 14, 2001
Localizing infection with a technetium-99m-labeled peptide: initial resultsC J Palestro, F L Weiland, J E Seabold, et al.Nuclear Medicine Communications|June 14, 2001
Quantification of reconstructed SPECT non-uniformityA HughesPageof 559